Skip to content

Sunshine Biopharma Inc.: filings

Every Sunshine Biopharma Inc. annual and quarterly report in the SEC record with the published financial measures it tagged, 64 filings, each linked to its SEC index.

Filings with published measures

Each page shows what one filing reported, as tagged in that filing, with the periods it covered. Later filings can restate a value; the company overview shows the latest-filed value per period.

FormFiledFiscal periodMeasuresFactsSEC accession
10-Q2026-08-13fiscal Q2 2026431190001683168-26-006340
10-Q2026-05-13fiscal Q1 202642890001683168-26-003819
10-K2026-04-03fiscal FY 2025491000001683168-26-002644
10-Q2025-11-13fiscal Q3 2025471310001683168-25-008328
10-Q2025-08-12fiscal Q2 2025471310001683168-25-005981
10-Q2025-05-15fiscal Q1 202547990001683168-25-003701
10-K2025-04-01fiscal FY 2024511050001683168-25-002184
10-Q2024-11-05fiscal Q3 2024431230001683168-24-007622
10-Q/A2024-08-20fiscal Q2 2024401170001683168-24-005931
10-Q2024-08-16fiscal Q2 2024401170001683168-24-005846
10-Q2024-05-20fiscal Q1 202439840001683168-24-003688
10-K2024-03-28fiscal FY 202346940001683168-24-001818
10-Q2023-11-13fiscal Q3 2023431230001683168-23-007911
10-Q2023-08-10fiscal Q2 2023441260001683168-23-005518
10-Q2023-05-10fiscal Q1 202339820001683168-23-003121
10-K2023-04-04fiscal FY 202243870001683168-23-002128
10-Q2022-11-07fiscal Q3 2022361080001683168-22-007290
10-Q2022-08-03fiscal Q2 2022371100001683168-22-005298
10-Q2022-05-06fiscal Q1 202236760001683168-22-003262
10-K2022-03-21fiscal FY 202142860001683168-22-001788
10-Q2021-11-09fiscal Q3 2021401140001683168-21-005363
10-Q2021-08-09fiscal Q2 2021391120001683168-21-003345
10-Q2021-05-11fiscal Q1 202139800001654954-21-005450
10-K2021-03-30fiscal FY 202041810001654954-21-003507
10-Q2020-11-12fiscal Q3 2020381080001654954-20-012128
10-Q/A2020-08-31fiscal Q2 2020371060001654954-20-009628
10-Q2020-08-19fiscal Q2 2020371060001654954-20-009340
10-Q2020-05-18fiscal Q1 202034700001654954-20-005714
10-K2020-05-01fiscal FY 201941820001654954-20-004731
10-Q2019-11-13fiscal Q3 201934980001654954-19-012832
10-Q2019-08-15fiscal Q2 201935980001654954-19-009672
10-Q2019-05-20fiscal Q1 201939780001654954-19-006301
10-K2019-04-12fiscal FY 201841830001654954-19-004354
10-Q2018-11-16fiscal Q3 201832860001654954-18-012900
10-Q2018-08-17fiscal Q2 201832860001654954-18-009279
10-Q2018-05-22fiscal Q1 201829580001654954-18-005724
10-K2018-04-02fiscal FY 201735700001654954-18-003495
10-Q2017-11-15fiscal Q3 201728740001654954-17-010704
10-Q2017-08-11fiscal Q2 201727720001654954-17-007370
10-Q2017-05-12fiscal Q1 201726520001654954-17-004568
10-K2017-04-17fiscal FY 201634690001654954-17-003365
10-Q2016-11-14fiscal Q3 201631800001654954-16-003935
10-Q2016-08-16fiscal Q2 201632820001654954-16-001658
10-Q2016-05-09fiscal Q1 201629580001354488-16-007274
10-K2016-03-25fiscal FY 201535710001354488-16-006700
10-Q2015-11-04fiscal Q3 201526700001354488-15-004810
10-Q2015-08-06fiscal Q2 201525660001354488-15-003598
10-Q2015-05-07fiscal Q1 201523460001354488-15-002193
10-K2015-03-11fiscal FY 201424490001354488-15-001081
10-Q2014-11-12fiscal Q3 201424640001354488-14-005565
10-Q2014-08-12fiscal Q2 201424640001354488-14-004103
10-Q2014-05-09fiscal Q1 201422540001354488-14-002379
10-K2014-03-19fiscal FY 201324680001354488-14-001275
10-Q2013-11-04fiscal Q3 201322540001354488-13-005974
10-Q2013-08-06fiscal Q2 201322540001354488-13-004212
10-Q2013-05-09fiscal Q1 201322520001354488-13-002516
10-K2013-03-15fiscal FY 201221570001354488-13-001224
10-Q2012-11-08fiscal Q3 201222690001354488-12-005637
10-Q2012-08-08fiscal Q2 201223710001354488-12-003912
10-Q2012-05-08fiscal Q1 201222550001354488-12-002208
10-K2012-03-19fiscal FY 201120540001354488-12-001221
10-Q2011-11-08fiscal Q3 201120590001354488-11-004118
10-Q2011-08-09fiscal Q2 201119550001354488-11-002548
10-Q2011-05-12fiscal Q1 201119450001354488-11-001463

Inspect the source

Entity
Sunshine Biopharma Inc. / CIK 0001402328
Captured
2026-09-20T08:00:47.083Z
SEC response SHA-256
089eb69bd01c2bc993f5073ccdb651eba31ddb7f7ea640d657095dcd4ddd9932

Current SEC company facts · Download the original response snapshot (gzip) · Download the selected JSON

Every published concept a filing tagged, with the periods it covered, as reported in that filing at capture time. Forms 10-K, 10-K/A, 10-Q, 10-Q/A, 20-F, 20-F/A, 40-F, 40-F/A. A filing page needs at least 8 published concepts. Later filings can restate these values; the company history pages show the latest-filed value per period.

Public company accounting reference, not market prices, returns, an investment recommendation, or ALPHAC performance. Validate a separately constructed return series with the validation API; accounting values are not returns.

Use this in research

A financial period ends before its results become public. Use the filing date as a minimum availability boundary, inspect amendments, and retain the original filing vintage when testing historical signals. This latest-filed selection can contain information unavailable at the time.

These pages do not supply prices, total-return histories, corporate-action adjustments or a tradable universe. Build those inputs separately before evaluating a strategy. A profitable backtest can still reflect selection bias or costs that were left out.

Research methodology · Execution and cost assumptions · Check backtest overfitting

Build with the open-source tools

Use these accounting records as inspectable inputs. When you have constructed a return series, the validation tools can help test its statistical evidence and preserve the result with its limitations.

Read the published dataset with Python
import json
from urllib.request import urlopen

with urlopen("https://canlicapital.com/company-data/0001402328.json") as response:
    record = json.load(response)
print(record["fetched_at"])
print(record["policy"])
for concept in record["concepts"]:
    print(concept["tag"], next(iter(concept["observations"])))